Acquired hypothalamic obesity is typically precipitated by hypothalamic insult from tumors, treatment, trauma, stroke, or ...
Morning Overview on MSN
Python blood compound is being studied for potential weight loss drugs
Researchers at the University of Colorado Boulder have identified a molecule in Burmese python blood that suppresses appetite ...
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and ...
PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care, announced that it was selected by Rhythm Pharmaceuticals, ...
The study, led by Zhang Zhi of the University of Science and Technology of China in eastern Anhui province, was published on ...
The FDA has approved an expanded indication for setmelanotide to treat children and adults with acquired hypothalamic obesity ...
Imcivree’s approval in a type of obesity driven by brain injury could unlock an opportunity Wall Street analysts believe to ...
First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or ...
Microglia (immune cells) and the RANK protein are essential for triggering puberty and maintaining fertility in the brain.
The kick off signal for puberty begins in the brain. Specifically, in the hypothalamus, where specific neurons release a hormone that activates the hypophysis, at the base of the skull, which then ...
Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results